BioCardia, Inc. (BCDA)

BioCardia Statistics

Total Valuation

BioCardia has a market cap or net worth of $13.37 million. The enterprise value is $13.13 million.

Market Cap	13.37M
Enterprise Value	13.13M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BioCardia has 10.61 million shares outstanding. The number of shares has increased by 163.54% in one year.

Current Share Class	10.61M
Shares Outstanding	10.61M
Shares Change (YoY)	+163.54%
Shares Change (QoQ)	+9.15%
Owned by Insiders (%)	19.76%
Owned by Institutions (%)	3.03%
Float	7.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.33

Current Ratio	0.33
Quick Ratio	0.27
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-222.28%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	570.12%
Revenue Per Employee	n/a
Profits Per Employee	-$439,700
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.93% in the last 52 weeks. The beta is 0.79, so BioCardia's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-47.93%
50-Day Moving Average	1.61
200-Day Moving Average	2.10
Relative Strength Index (RSI)	37.52
Average Volume (20 Days)	227,058

Short Selling Information

The latest short interest is 306,467, so 2.89% of the outstanding shares have been sold short.

Short Interest	306,467
Short Previous Month	198,824
Short % of Shares Out	2.89%
Short % of Float	4.03%
Short Ratio (days to cover)	0.21

Income Statement

Revenue	n/a
Gross Profit	-5.24M
Operating Income	-8.85M
Pretax Income	-8.79M
Net Income	-8.79M
EBITDA	-8.81M
EBIT	-8.85M
Earnings Per Share (EPS)	-$2.05

Balance Sheet

The company has $980,000 in cash and $745,000 in debt, giving a net cash position of $235,000 or $0.02 per share.

Cash & Cash Equivalents	980,000
Total Debt	745,000
Net Cash	235,000
Net Cash Per Share	$0.02
Equity (Book Value)	-1.89M
Book Value Per Share	-0.34
Working Capital	-2.44M

Cash Flow

In the last 12 months, operating cash flow was -$8.45 million and capital expenditures -$4,000, giving a free cash flow of -$8.46 million.

Operating Cash Flow	-8.45M
Capital Expenditures	-4,000
Free Cash Flow	-8.46M
FCF Per Share	-$0.80

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-163.54%
Shareholder Yield	-163.54%
Earnings Yield	-65.79%
FCF Yield	-63.25%

Analyst Forecast

The average price target for BioCardia is $25.00, which is 1,884.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	1,884.13%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	248.63%
EPS Growth Forecast (5Y)	-24.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 30, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	May 30, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

BioCardia has an Altman Z-Score of -124.44 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-124.44
Piotroski F-Score	1